Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls
This study is to investigate the physiological mechanism of oxytocin system stimulation using 3,4-methylenedioxymethamphetamine (MDMA) as a physiological tool (acute oxytocin releases), not as a medication. This study seeks to test whether the oxytocin response after MDMA administration is different between individuals with autism spectrum disorder and matched healthy controls.
- Status
- planned
- Institution
- University Hospital, Basel, Switzerland
- Principal investigator
- Mirjam Christ-Crain, Prof. Dr. med.
- Start date
- 2026-06-01
- End date
- 2028-06-01
- Registry ID
- NCT07555132
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.